Department of Surgery, Catharina Hospital, PO Box 1350, 5602 ZA, Eindhoven, the Netherlands.
Department of Surgery, Catharina Hospital, PO Box 1350, 5602 ZA, Eindhoven, the Netherlands.
Eur J Surg Oncol. 2024 Jun;50(6):108259. doi: 10.1016/j.ejso.2024.108259. Epub 2024 Mar 19.
Despite advancements in colorectal cancer care, one-year post-operative mortality rates remain high for elderly patients who have undergone curative surgery for primary clinical T4 rectal cancer (cT4RC) or locally recurrent rectal cancer (LRRC). This study aimed to identify factors associated with one-year mortality and to evaluate the causes of death.
MATERIALS & METHODS: This retrospective cohort study included patients aged ≥70 years who underwent surgery with curative intent for cT4RC or LRRC between January 2013 and December 2020. Clinical and follow-up data were collected and analyzed to determine survival rates and investigate factors associated with mortality within one year after surgery.
A total of 183 patients (94 cT4RC, 89 LRRC) were included. One-year mortality rates were 16.0% for cT4RC and 28.1% for LRRC (P = 0.064). In cT4RC patients, factors associated with one-year mortality were preoperative anemia (OR 3.83, P = 0.032), total pelvic exenteration (TPE) (OR 7.18, P = 0.018), multivisceral resections (OR 5.73, P = 0.028), pulmonary complications (OR 13.31, P < 0.001) and Clavien-Dindo grade ≥ III complications (OR 5.19, P = 0.025). In LRRC patients, factors associated with one-year mortality were TPE (OR 27.00, P = 0.008), the need for supported care after discharge (OR 3.93, P = 0.041) and Clavien-Dindo grade ≥ III complications (OR 3.95, P = 0.006). The main causes of death in cT4RC and LRRC patients were failure to recover (cT4RC 26.6%, LRRC 28.0%) and disease recurrence (cT4RC 26.6%, LRRC 60.0%).
In order to tailor treatment in elderly with cT4RC and LRRC, factors associated with increased one-year mortality (e.g. pre-operative anemia, TPE) should be incorporated in the decision-making process.
Not applicable.
尽管在结直肠癌治疗方面取得了进展,但对于接受根治性手术治疗原发性临床 T4 直肠肿瘤(cT4RC)或局部复发性直肠肿瘤(LRRC)的老年患者,术后一年死亡率仍然很高。本研究旨在确定与一年死亡率相关的因素,并评估死亡原因。
这是一项回顾性队列研究,纳入了 2013 年 1 月至 2020 年 12 月期间接受根治性手术治疗 cT4RC 或 LRRC 的年龄≥70 岁的患者。收集并分析了临床和随访数据,以确定生存率并调查术后一年内与死亡率相关的因素。
共纳入 183 例患者(94 例 cT4RC,89 例 LRRC)。cT4RC 患者的一年死亡率为 16.0%,LRRC 患者的一年死亡率为 28.1%(P=0.064)。在 cT4RC 患者中,与一年死亡率相关的因素包括术前贫血(OR 3.83,P=0.032)、全盆腔切除术(OR 7.18,P=0.018)、多脏器切除术(OR 5.73,P=0.028)、肺部并发症(OR 13.31,P<0.001)和 Clavien-Dindo 分级≥3 级并发症(OR 5.19,P=0.025)。在 LRRC 患者中,与一年死亡率相关的因素包括全盆腔切除术(OR 27.00,P=0.008)、出院后需要支持性护理(OR 3.93,P=0.041)和 Clavien-Dindo 分级≥3 级并发症(OR 3.95,P=0.006)。cT4RC 和 LRRC 患者死亡的主要原因是无法康复(cT4RC 26.6%,LRRC 28.0%)和疾病复发(cT4RC 26.6%,LRRC 60.0%)。
为了针对 cT4RC 和 LRRC 的老年患者进行个体化治疗,应将与一年死亡率增加相关的因素(如术前贫血、全盆腔切除术)纳入决策过程。
不适用。